Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Influenza Congress USA

12 Nov 2012 - 13 Nov 2012 - Washington DC, USA



Bookmark and Share


Innovation and opportunity for pharma, biotech, healthcare and investors 

The 4th annual Influenza Congress USA is where key decision makers from pharma, biotech and government come together to plan their development strategies and share best practice with their peers in ‘flu vaccine manufacturing.

Last year, we had senior executives from GSK, Novartis, Sanofi Pasteur, CSL and over 100 other companies discussing adjuvant approval in the US, universal vaccine development, cell-based vaccine development, biotech partnering and funding, delivery, experimental challenge studies and novel egg-based vaccine manufacturing.

Come to Influenza Congress USA and learn:


· How to grow business in light of current developments – H5N1, adjuvant approval, 

cell-based vaccine commercialization, low volume manufacturing

· How to navigate regulatory compliance

· How to fast track FDA approval

· How to monetize new discoveries sooner

· How to eliminate research and manufacturing bottlenecks

· How to attract investment and funding

· How to choose partners

· How to identify the most cost-effective technologies


Can you afford not to be here?


For more information contact, please visit our website, www.terrapinn.com/influenza, or call +1 212 379 6320.



Further information
Scientific News
New Regulator of Immune Reaction Discovered
Calcium signal in cell nucleus regulates not only many brain functions but also defence reactions of the immune system.
First Steps to Neutralising Zika
Researchers have discovered a highly potent antibody that neutralises Zika infection at a cellular level.
Cell’s ‘Built-In Circuit’ Help Prevent Tumour Growth
Researchers have created cells with a 'built-in genetic circuit' that inhibits tumour growth.
Factors Behind Suppression of Stem Cell Mobilization Revealed
The findings could lead to improvements in transplantation therapy.
Common Virus Helps Fight Liver Cancer
Reovirus, a cause of childhood colds, stimulates the immune system to kill cancerous cells.
Antibody Protects Mice from Zika Infection
Researchers develop human-derived antibody protected pregnant mice and their developing fetuses from Zika infection.
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
T Cell Channel Could Be Targeted to Treat Cancers
Researcher identify ion-channel found within T cells that could be targeted to reduce development of neck and head cancers.
Targeting Pancreatic Cancer
Cutting-edge technology exploits cancer cells’ vulnerabilities to develop new treatments.
A Genome-wide View of Human DNA Viruses
In this study, Duplex sequencing was used to accurately analyse the genome-wide rate of spontaneous mutation of human adenovirus C5 (HAdv5).
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!